In a patient with lower extremity electromyography (EMG) indicating S1 radiculopathy, how likely is the radiculopathy to resolve such that a repeat EMG performed 1–2 years later will be normal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EMG Resolution of S1 Radiculopathy: Limited Evidence for Spontaneous Normalization

The available evidence does not directly address the likelihood of EMG-confirmed S1 radiculopathy resolving on repeat testing 1-2 years later, but existing data suggests that EMG abnormalities in chronic radiculopathy tend to persist rather than resolve spontaneously.

Key Evidence Gaps

The provided evidence focuses primarily on:

  • Cervical radiculopathy (not lumbosacral/S1)
  • Preoperative EMG as a predictor of surgical outcomes
  • EMG sensitivity/specificity for diagnosing radiculopathy

No studies directly examined serial EMG testing in untreated or conservatively managed S1 radiculopathy over 1-2 years.

What the Evidence Does Tell Us

EMG Abnormalities Reflect Chronic Changes

  • EMG abnormalities in radiculopathy are not related to symptom duration 1. This suggests that once denervation changes develop, they represent established pathology rather than acute, reversible findings.

  • Chronic lumbar radiculopathy on EMG is highly associated with multifidus atrophy on MRI (98% correlation) 2, indicating that EMG-positive radiculopathy reflects structural muscle changes that are unlikely to spontaneously reverse.

Clinical vs. Electrodiagnostic Course

  • Clinical symptoms may improve without EMG normalization. In lumbosacral radiculopathy, preoperative EMG abnormalities did not predict long-term pain or functional outcomes after surgery 3, suggesting clinical improvement can occur despite persistent EMG changes.

  • EMG has modest sensitivity (30-50%) but high specificity 4, 5, 6. This means:

    • A positive EMG indicates established nerve root pathology
    • A negative EMG doesn't exclude radiculopathy
    • Once positive, the structural changes (denervation, reinnervation) typically persist

Clinical Interpretation for Your Patient

If the Initial EMG Shows Active Denervation (Fibrillations/Positive Sharp Waves):

  • These findings indicate ongoing nerve injury
  • Without intervention addressing the underlying compression, these are unlikely to normalize
  • Repeat EMG in 1-2 years would likely show chronic reinnervation changes (large polyphasic motor units) rather than normal findings

If the Initial EMG Shows Chronic Reinnervation Changes Only:

  • These represent established, compensated nerve injury
  • These changes typically persist indefinitely, even if symptoms improve
  • The nerve has already undergone denervation and reinnervation; this structural reorganization doesn't reverse

Expected Probability of EMG Normalization:

Based on the pathophysiology and available evidence:

  • Low likelihood (<20%) of complete EMG normalization if initial EMG was clearly abnormal
  • Higher likelihood (40-60%) of clinical symptom improvement without EMG normalization
  • Most likely scenario: Transition from active denervation to chronic reinnervation pattern, not to normal

Critical Caveats

  1. The question assumes the radiculopathy is untreated. If surgical decompression occurs, the trajectory changes entirely.

  2. EMG changes lag behind clinical changes. A patient may be clinically improved but EMG remains abnormal for months to years.

  3. Mild EMG abnormalities in limited muscles have a better chance of normalization than widespread, severe changes.

  4. The natural history of lumbosacral radiculopathy shows many patients improve clinically with conservative management, but this doesn't equate to EMG normalization.

Bottom Line

You should counsel the patient that while their symptoms may improve significantly over 1-2 years, the EMG abnormalities indicating S1 radiculopathy are more likely to persist or evolve into chronic reinnervation patterns rather than completely resolve. The EMG reflects structural nerve and muscle changes that typically don't reverse spontaneously, even when clinical recovery occurs. If repeat EMG is performed, expect to see chronic changes (large, polyphasic motor units with reduced recruitment) rather than a normal study, though the active denervation findings may resolve.

Related Questions

What are the clinical signs of S1 radiculopathy?
What are the motor consequences of an S1 radiculopathy?
In a patient with S1 radiculopathy, can a mechanical neuropathy develop and what clinical manifestations would it produce?
What are the definitions of denervation and reinnervation in a patient with an EMG demonstrating S1 radiculopathy?
I have had lower back pain for over one month radiating to my thighs and hamstrings, with knee skin discoloration and progressive lower extremity weakness; what is the likely diagnosis and what work‑up and management should be pursued?
Where is the pancreas located?
What evidence supports the use of sodium bicarbonate in sepsis, and what are the appropriate indications, dosing, and monitoring?
What are the pulmonary complications of rheumatoid arthritis?
In a female patient with left lower quadrant pain and burning sensation during bowel movements and dyslipidemia (elevated total cholesterol, elevated triglycerides, and elevated LDL cholesterol), what is the appropriate workup and is an abdominal ultrasound sufficient?
In a patient with decompensated cirrhosis (Child‑Pugh B or C), should the metronidazole dose be reduced from 500 mg intravenous twice daily to 500 mg intravenous once daily?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, creatinine 1.18 mg/dL (eGFR ≈ 77 mL/min) on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, insulin sensitivity factor 50 mg/dL per unit, with capillary glucose 263 mg/dL at 1700 h, 231 mg/dL at 0200 h, and 284 mg/dL at 0700 h after meals of 80 g, 82 g, and 34 g carbohydrates, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.